The world of probiotics is undergoing a paradigm shift, and it's all about traceability and functionality. At the Growth Asia Summit 2026, TCI's R&D Manager, Lucas Chang, highlighted the evolution of probiotic delivery from a logistical challenge to a biological one. Instead of just ensuring survival and arrival, the focus is now on understanding the complex interplay between the gut, its ecosystem, and various bodily functions.
Chang emphasizes the importance of traceability in the 'evidence chain' - the process of linking microbiome function, bioactive compound production, host response, and measurable impact at distant sites. This is crucial for healthy aging, as the body's ability to handle pressure changes over time. The key is not to avoid aging but to understand and adapt to the body's evolving challenges.
Aging is not a linear process; it involves major disruptions at specific checkpoints. The first transition occurs around 40, affecting lipid metabolism, alcohol metabolism, and cardiovascular health. The second transition, around 60, involves immune regulation, carbohydrate metabolism, and oxidative stress. Chang illustrates this point by comparing two individuals of the same age but with vastly different functional trajectories.
TCI's approach to probiotics is innovative. They've developed TCR711, a spore-forming probiotic strain, to address two common aging stresses: fat accumulation and alcohol metabolism. In a study involving adults with non-alcohol fatty liver disease, TCR711 significantly reduced liver fat accumulation. Interestingly, the gut ecology also shifted, indicating that the probiotic's effects extend beyond the liver.
The study further demonstrated TCR711's ability to enhance alcohol clearance. Participants who supplemented with TCR711 exhibited faster alcohol-clearance signals after a whiskey shot challenge. This finding highlights the strain's alcohol dehydrogenase and aldehyde dehydrogenase capabilities.
Chang stresses that functional probiotic design goes beyond delivery. It's about creating a strain that performs a specific job after arrival. This requires a reverse approach, starting with the desired health outcome and tracing the biology backward. TCI's liquid chocolate probiotic is an example of this, offering a convenient and tasty way to consume probiotics daily.
In conclusion, the future of probiotics is about traceability and functionality. By understanding the complex gut-axis science and the body's evolving challenges, we can develop probiotics that not only survive but also actively contribute to healthy aging. TCI's innovative approach and focus on traceability and functionality are paving the way for a new era in probiotic technology.
